Robert Hayman
DirectoratEvolus· In proxies 2023–2024
Robert Hayman sits on 5 public boards.
Experience
- EvolusPublic company · 3 yr
- Director2023 – Present · 3 yrStock in role +17%
- Melinta Therapeutics, IncPublic company
- Director? – PresentNo stock prices for these years
- Strongbridge Biopharma, PLCPublic company · 2 yr
- Director2019 – 2021 · 2 yrNo stock prices for these years
- Strata Skin SciencesPublic company · 2 yr
- Director2018 – 2020 · 2 yrNo stock prices for these years
- Cempra Inc.Public company · 8 yr
- Director2012 – 2020 · 8 yrNo stock prices for these years
- Histogenics, Inc.Public company · 4 yr
- Director2015 – 2019 · 4 yrNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?